MusclePharm Corporation Convertible Notes Payable
MusclePharm Corporation had Convertible Notes Payable of $5.33 million as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2022-05-16
- 2022-03-31: Convertible Notes Payable $5.33M.
- 2021-12-31: Convertible Notes Payable $5.33M.
- 2021-03-31: Convertible Notes Payable $2.87M.
- 2020-12-31: Convertible Notes Payable $2.87M.
| Period end | Convertible Notes Payable |
|---|---|
| 2022-03-31 | $5.33M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $5.33M 10-Q · filed 2022-05-16 |
| 2021-03-31 | $2.87M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $2.87M 10-K/A · filed 2022-05-04 |
| 2020-09-30 | $2.73M 10-Q · filed 2020-11-24 |
| 2020-06-30 | $1.03M 10-Q · filed 2020-11-24 |
| 2020-03-31 | $1.03M 10-Q · filed 2020-11-24 |
| 2019-12-31 | $1.29M 10-K · filed 2021-03-29 |
| 2019-09-30 | $1.16M 10-Q · filed 2020-08-25 |
| 2019-06-30 | $18.00M 10-Q · filed 2020-08-25 |
| 2019-03-31 | $18.00M 10-Q · filed 2020-08-25 |
| 2018-12-31 | $18.00M 10-Q · filed 2020-08-25 |
| 2018-09-30 | $18.00M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $18.00M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $18.00M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $18.00M 10-Q · filed 2018-11-14 |
| 2017-09-30 | $18.00M 10-Q · filed 2017-11-14 |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 |